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S U M M A R Y
Objectives: To determine the rate of device-associated healthcare-associated infection (DA-HAI),
microbiological proﬁle, length of stay (LOS), extra mortality, and hand hygiene compliance in two
intensive care units (ICUs) of two hospital members of the International Infection Control Consortium
(INICC) of Havana, Cuba.
Methods: An open label, prospective cohort, active DA-HAI surveillance study was conducted on adults
admitted to two tertiary-care ICUs in Cuba from May 2006 to December 2009, implementing the
methodology developed by INICC. Data collection was performed in the participating ICUs, and data
were uploaded and analyzed at the INICC headquarters on proprietary software. DA-HAI rates were
registered by applying the deﬁnitions of the US Centers for Disease Control and Prevention National
Healthcare Safety Network (CDC NHSN). We analyzed the mechanical ventilator-associated pneumonia
(VAP), central line-associated bloodstream infection (CLA-BSI), and catheter-associated urinary tract
infection (CAUTI) rates, microorganism proﬁle, extra length of stay (ELOS), extra mortality, and hand
hygiene compliance.
Results: During 14 512 days of hospitalization, 1982 patients acquired 444 DA-HAIs, an overall rate of
22.4% (95% CI 20.6–24.3) or 30.6 (95% CI 27.8–33.5) DA-HAIs per 1000 ICU-days. The CLA-BSI ratewas 2.0
(95% CI 1.2–3.1) per 1000 central line-days, the VAP ratewas 52.5 (95% CI 47.2–58.3) per 1000 ventilator-
days, and the CAUTI rate was 8.1 (95% CI 6.5–10.0) per 1000 catheter-days. LOS of patients was 4.9 days
for thosewithout DA-HAI, 23.3 days for thosewith CLA-BSI, and 23.8 days for those with VAP. CAUTI LOS
was not calculated due to the lack of data. Extramortality was 47% (relative risk (RR) 2.42; p = 0.0693) for
VAP and 17% (RR 1.52; p = 0.5552) for CLA-BSI. The only patient with CAUTI died, but there was too little
mortality data regarding this infection type to consider this signiﬁcant. Escherichia coli was the most
commonly isolated microorganism. The overall hand hygiene compliance was 48.6% (95% CI 42.8–54.3).
Conclusions: DA-HAI rates, LOS, and mortality were found to be high, and hand hygiene low. It is of
primary importance that infection control programs that include outcome and process surveillance are
implemented in Cuba.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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In the USA, as well as in several other high-income countries,
device-associated healthcare-associated infection (DA-HAI) sur-
veillance in the intensive care unit (ICU) plays a substantial role in
hospital infection control and quality assurance.1 Likewise,* Corresponding author at: Corrientes Ave #4580, Floor 12, Apt D, Buenos Aires
City, ZIP 1195, Argentina. Tel.: +54 11 4861 5826.
E-mail address: victor_rosenthal@inicc.org (V.D. Rosenthal).
1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.02.001surveillance has been reported by the US Centers for Disease
Control and Prevention (CDC) Study of the Efﬁcacy of Nosocomial
Infection Control (SENIC) as an efﬁcacious tool to reduce DA-HAIs.2
In an increasingly large quantity of the scientiﬁc literature, DA-
HAIs are considered the principal threat to patient safety in the ICU,
and are among the main causes of patient morbidity and
mortality.3–5 The CDC’s National Nosocomial Infection Surveillance
System (NNIS) and National Healthcare Safety Network (NHSN)
have reported standardized criteria for DA-HAI surveillance.6,7 This
standardized surveillance method allows for the determination of
DA-HAI rates per 1000 device-days, comparable among healthcareses. Published by Elsevier Ltd. All rights reserved.
Table 1
Features of the International Nosocomial Infection Control Consortium hospitals
and intensive care units; hospitals A and B, Havana, Cuba, May 2006–December
2009
Variable Medical–surgical ICU Trauma ICU Overall
ICUs, n 1 1 2
Hospitals, n (%) 1 1 2
Academic teaching 1 1 2 (100%)
Public 0 0 0
Private community 0 0 0
Patients studied, n 836 1146 1982
Total ICU days 4762 9750 14 512
Device usea
Ventilator-days 1902 4515 6417
Ventilator use 0.40 0.46 0.44
Central line-days 3028 6863 9891
Central line use 0.64 0.70 0.68
Urinary catheter-days 3867 6822 10 689
Urinary catheter use 0.81 0.70 0.74
ICU, intensive care unit.
a Device utilization (DU): DU ratios were calculated by dividing the total number
of device-days by the total number of patient-days. Device-days are the total
number of days of exposure to the device (central line, mechanical ventilator, or
urinary catheter) by all of the patients in the selected population during the selected
time period. Patient-days are the total number of days that patients are in the ICU
during the selected time period.
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in-depth look at the institutional problems they are confronted
with, so as to provide an effective solution to them.In the context of
an expanded framework for DA-HAI control, most of the relevant
studies of ICU-acquired infections have been carried out in the
industrialized countries.8 In the developing countries, however,
only a few published studies have reported DA-HAI rate data using
standardized deﬁnitions.9–17The International Infection Control
Consortium (INICC) was founded in 1998 when selected hospitals
from Latin America were invited to participate in the project in
order to measure DA-HAI using standardized deﬁnitions and
methodology.18 Shortly afterwards, other hospitals located in
different parts of the world also requested membership of the
INICC. Currently, the INICC comprises a worldwide network of
around 250 ICUs from 38 countries of Latin America, Asia, Africa,
and Europe.9–17
On a monthly basis, healthcare facilities send routinely
gathered prospective data to the INICC, which are then entered
into an international database. Hospital members of the INICC
provide general medical and surgical inpatient services to adults
and children hospitalized in the ICUs.
The ﬁndings of the present study from Cuba form an integral
part of the INICC project, and reﬂect the systematically collected
outcome and process surveillance data.
2. Methods
2.1. Setting
The study was carried out in two ICUs in two hospitals of
Havana, Cuba, from May 2006 to December 2009. The hospitals
each have an infection control team (ICT) with a physician and an
ICP with at least 5 years of experience in infection control and a
microbiology laboratory to provide in vitro susceptibility testing of
clinical isolates using standardized methods. Each hospital’s
institutional review board approved the study protocol. Patient
conﬁdentiality was protected by codifying the recorded informa-
tion, making it only identiﬁable to the ICT.
2.2. Surveillance
Data were collected prospectively on a daily basis from all the
patients admitted to the ICUs, by means of speciﬁcally designed
forms. The data were gathered according to the DA-HAI deﬁnitions
provided by the CDC-NNIS and CDC-NHSN,6,7 and methodology of
the INICC.18
2.3. Hand hygiene compliance surveillance
Hand hygiene compliance by healthcare workers (HCWs) at the
ICU is monitored by the ICP through observations of a randomly
selected 1-h period, three times a week, during all working shifts
and including all HCWs, according to a speciﬁc sequence set forth
in the INICC protocol. The ICP records the opportunities for hand
hygiene and compliance before contact with each patient on a
speciﬁc surveillance form designed by the INICC.18
2.4. Culture techniques
For central line-associated bloodstream infection (CLA-BSI),
central lines were removed aseptically and the distal 5 cm of the
catheter was amputated and cultured using a standardized
semiquantitative method.19 Concomitant blood cultures were
drawn percutaneously in nearly all cases. For ventilator-associated
pneumonia (VAP), in most cases, a deep tracheal aspirate from the
endotracheal tube was cultured aerobically and Gram-stained. Forcatheter-associated urinary tract infection (CAUTI), a urine sample
was aseptically aspirated from the sampling port of the urinary
catheter and cultured quantitatively.
In all cases, standard laboratory methods were used to identify
microorganisms, and a standardized susceptibility test was
performed.20
2.5. Calculation of device-associated infection rates
Outcomes measured during the surveillance period included
the incidence density rate of CLA-BSI (number of cases per 1000
central line-days), of CAUTI (number of cases per 1000 urinary
catheter-days), and of VAP (number of cases per 1000 mechanical
ventilator-days).
DA-HAI rates for VAP, CLA-BSI, and CAUTI per 1000 device-days
were calculated by dividing the total number of DA-HAI by the
total number of speciﬁc device-days and multiplying the result by
1000.21
Device utilization (DU) ratios were calculated by dividing the
total number of device-days by the total number of patient-days.
Device-days are the total number of days of exposure to the device
(central line, ventilator, or urinary catheter) for all of the patients in
the selected population during the selected time period. Patient-
days are the total number of days that patients are in the ICU
during the selected time period.21
2.6. Length of stay and mortality calculation
Length of stay (LOS) and mortality was collected prospectively
when ﬁlling out INICC forms daily.
The extra LOS is the difference between the LOS of patients with
a DA-HAI and the LOS of patients hospitalized in the ICU during
that period who did not acquire a DA-HAI.18
The crude extra mortality was calculated as the difference
between the crude overall case-fatality of patients with a DA-HAI
and the crude case-fatality of patients hospitalized in the ICU
during that period who did not acquire a DA-HAI.18
2.7. Statistical analysis
EpiInfo version 6.04b (CDC, Atlanta, GA, USA) and SPSS 16.0
(IBM SPSS, Chicago, IL, USA)were used to conduct the data analysis.
Table 2
Device-associated infections per 1000 device-days: VAP, CLA-BSI, and CAUTI; hospitals A and B, Havana, Cuba, May 2006–December 2009
Infection site Device type Device-days DA-HAI Distribution of device
associated DA-HAI (%)
Rate per 100
patients
Rate per 1000
device-daysa
VAP (overall rate) MV 6417 337 76% 17.0% 52.5 (95% CI 47.2–58.3)
Trauma ICU MV 4515 298 78% 26.0% 66.0 (95% CI 58.9–73.7)
Medical–surgical ICU MV 1902 39 63% 4.7% 20.5 (95% CI 14.6–27.9)
CLA-BSI (overall rate) CL 9891 20 4% 1.0% 2.0 (95% CI 1.2–3.1)
Trauma ICU CL 6863 13 3% 1.1% 1.9 (95% CI 1.0–3.3)
Medical–surgical ICU CL 3028 7 11% 0.8% 2.3 (95% CI 0.9–4.8)
CAUTI (overall rate) UC 10 689 87 20% 4.4% 8.1 (95% CI 6.5–10.0)
Trauma ICU UC 6822 71 19% 6.2% 10.4 (95% CI 8.1–13.1)
Medical–surgical ICU UC 3867 16 26% 1.9% 4.1 (95% CI 2.4–6.7)
VAP, Ventilator-associated pneumonia; CLA-BSI, central line-associated blood stream infection; CAUTI, catheter-associated urinary tract infection; DA-HAI, device-associated
healthcare-associated infection; ICU, intensive care unit; MV, mechanical ventilator; CL, central line; UC, urinary catheter; CI, conﬁdence interval.
a Rate per 1000 device-days: rates were calculated by dividing the total number of DA-HAIs by the total number of speciﬁc device-days for all of the patients in the selected
population during the selected time-period and multiplying the result by 1000.
Table 3
Hand hygiene compliance in the participating ICUs—comparison per stratum; hospital A, Havana, Cuba, May 2006–December 2009
Variable % (No. HH/No. opportunities) Comparison RR 95% CI p-Value
Gender
Female 45.2% Female vs. male 1.15 0.83–1.58 0.3921
Male 51.9%
Healthcare worker
Nurses 49.3% Nurses vs. physicians 1.48 0.21–10.57 0.6950
Physicians 43.3% Nurses vs. ancillary staff 1.14 0.64–2.01 0.6574
Ancillary staff 33.3% Physicians vs. ancillary staff 1.30 0.17–9.94 0.7998
Procedure
Non-invasive 46.3% Non-invasive vs. invasive 1.15 0.82–1.61 0.4218
Invasive 53.1%
Work shift
Morning 49.5% Morning vs. afternoon 1.05 0.76–1.46 0.7746
Afternoon 47.2%
ICU, intensive care unit; HH, hand hygiene; RR, relative risk; CI, conﬁdence interval.
Table 4
Extra mortality for patients with device-associated nosocomial infections in the medical–surgical ICU; hospital A, Havana, Cuba, May 2006–December 2009
Patients (n)a Crude mortality Extra mortality RR 95% CI p-Value
Patients without infection, % 782 33% - 1.0
Patients with CLA-BSI, % 4 50% 17% 1.52 0.4–6.1 0.5552
Patients with VAP, % 5 80% 47% 2.42 0.9–6.5 0.0693
ICU, intensive care unit; RR, relative risk; CI, conﬁdence interval; CLA-BSI, central line-associated bloodstream infection; VAP, ventilator-associated pneumonia.
a We only considered cases of patients with a single infection to calculate mortality.
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continuous variables were used to analyze baseline differences
among rates. Relative risk (RR) ratios, 95% conﬁdence intervals
(CIs), and p-values were determined for all primary and secondary
outcomes.
3. Results
3.1. Features of the study population
During the 3 years and 7 months of study, surveillance data
were prospectively collected for 1982 patients hospitalized in the
ICUs over 14 512 ICU-days (Table 1). The two participating
hospitals were academic teaching facilities. These patients
acquired 444 DA-HAIs, an overall rate of 22.4% (95% CI 20.6–
24.3) or 30.6 (95% CI 27.8–33.5) DA-HAIs per 1000 ICU-days. CLA-
BSI represented 5% of all DA-HAIs, VAP represented 76%, and CAUTI
represented 20% (Table 2). Individual characteristics of each ICU,
the number of patients enrolled in the study, the number of ICU-
days, and the device-days are shown in Table 1. One of the two ICUs
collected and sent original data to the INICC headquarters, and the
other collected and sent aggregated data to the INICC. We onlycalculated mortality, LOS, bacterial proﬁle, and hand hygiene from
the original data.
3.2. Device utilization (DU) ratio
TheDU ratio formechanical ventilation usewas 0.44, for central
line use was 0.68, and for urinary catheter use was 0.74. DA-HAI
distribution and device utilization are shown in Table 1.
3.3. Hand hygiene compliance
The total number of hand hygiene opportunities observed was
311. The overall hand hygiene compliance rate was 48.6% (95% CI
42.8–54.3). There were no signiﬁcant differences between the
strata compared (Table 3).
3.4. DA-HAI rates, mortality, and length of stay
3.4.1. CLA-BSI
CLA-BSI rates ranged from 1.9 to 2.3 per 1000 central line-days,
with an overall rate in the two ICUs of 2.0 per 1000 central line-
days (95% CI 1.2–3.1) (Table 2).
Table 5
Extra length of stay for patients with device-associated nosocomial infections in the medical–surgical ICU; hospital A, Havana, Cuba, May 2006–December 2009
Average length of stay Extra length of stay RR 95% CI
Patients without infection, days 4.9 – 1.0 4.6–5.2
Patients with CLA-BSI, days 23.3 18.3 4.7 9.4–85.8
Patients with VAP, days 23.8 18.9 4.9 10.5–73.3
ICU, intensive care unit; RR, relative risk; CI, conﬁdence interval; CLA-BSI, central line-associated bloodstream infection; VAP, ventilator-associated pneumonia.
Table 6
Microorganism proﬁle in the participating ICUs; hospital A, Havana, Cuba, May 2006–December 2009
Microorganism related to DA-HAI CLA-BSI- related VAP-related CAUTI-related Overall %
Acinetobacter spp 33.3% 15.4% 0% 10.3%
Escherichia coli 33.3% 15.4% 53.8% 34.5%
Klebsiella spp 0% 23.1% 15.4% 17.2%
Pseudomonas spp 0% 30.8% 7.7% 17.2%
Streptococcus pneumoniae 0% 7.7% 0% 3.4%
Coagulase-negative staphylococci 33.3% 7.7% 23.1% 17.2%
ICU, intensive care unit; DA-HAI, device-associated healthcare-associated infections; CLA-BSI, central line-associated blood stream infection; VAP, ventilator-associated
pneumonia; CAUTI, catheter-associated urinary tract infection.
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infection was 33%. The crude mortality of patients with a CLA-BSI
was 50%, with extra mortality for CLA-BSI of 17% (RR 1.52, 95% CI
0.4–6.1, p = 0.5552) (Table 4).
The LOS of patients without DA-HAI was 4.9 days (95% CI 4.6–
5.2) and the LOS of patients with a CLA-BSI was 23.3 days (95% CI
9.4–85.8), yielding an extra LOS of 18.3 days (RR 4.7) (Table 5).
3.4.2. VAP
VAP rates rangedwidely, from 20.5 to 66.0 per 1000mechanical
ventilator-days, with an overall rate in the two ICUs of 52.5 per
1000 mechanical ventilator-days (95% CI 47.2–58.3) (Table 2).
The crudemortality of patientswith VAPwas 80%, with an extra
mortality of 47% (RR 2.42, 95% CI 0.9–6.5, p = 0.0693) (Table 4).
The LOS of patients without a DA-HAI was 4.9 days and the LOS
of patients with VAP was 23.8 days (95% CI 10.5–73.3), yielding an
extra LOS of 18.9 days (RR 4.9) (Table 5).
3.4.3. CAUTI
The CAUTI rate ranged from 4.1 to 10.4 per 1000 urinary
catheter-days, with an overall rate in the two ICUs of 8.1 per 1000
urinary catheter-days (95% CI 6.5–10.0) (Table 2).
3.5. Overall microorganism proﬁle
Overall, 34.5% of all DA-HAI were caused by Escherichia coli,
17.2% by Klebsiella spp, 17.2% by Pseudomonas spp, 17.2% by
coagulase-negative staphylococci, 10.3% by Acinetobacter spp, and
3.4% by Streptococcus pneumoniae (Table 6).
4. Discussion
DA-HAIs pose a serious threat to patient safety, being among of
the most serious causes of morbidity and attributable mortality in
resource-limited countries. However, insufﬁcient data are avail-
able from these settings in the developing world.9–17,22–30 In
addition, it has been reported that DA-HAIs are a primary cause of
healthcare cost increases.9,10,31,32 Nevertheless, according to
several scientiﬁc studies carried out in the USA, which have
included targeted device-associated surveillance in their infection
control programs, it is possible to reduce the incidence of DA-HAIs
by as much as 30%, resulting in a correlative reduction in
healthcare costs.2
In a study conducted in 139 Cuban hospitals in 2004, the global
HAI prevalence was 7.3% (95% CI 6.3–7.9), but since this representsthe rate for the whole hospital, it is not comparable to our ICU
rate.33 In accordance with the results of another study from seven
Cuban university hospitals, the ICU HAI rate per 100 patients was
16.4, which is lower than our present rate of 22.4%.34
The CLA-BSI rate was 2.0 (95% CI 1.2–3.1) per 1000 central line-
days in this study, which is lower than the INICC reported rate (7.4
per 1000 central line-days, 95% CI 7.2–7.7), but similar to that of
the NHSN: 1.5 (95% CI 1.4–1.6).
On the other hand, the VAP rate was higher in this study (52.5
per 1000 mechanical ventilator-days, 95% CI 47.2–58.3) than the
one in the INICC report (14.7 per 1000 mechanical ventilator-days,
95% CI 14.2–15.2)12 or in the NHSN (1.9 per 1000 mechanical
ventilator-days, 95% CI 1.8–2.1). This may be explained by the
considerable level of practice variation concerning mechanical
ventilator care.35,36 We found that the VAP rate in our trauma ICU
was three times higher than that in our medical–surgical ICU;
similarly in the NSHN report, VAP rates in the trauma ICU are three
times higher than in the medical–surgical ICU.
The CAUTI rate was 8.1 per 1000 catheter-days in this study,
which is slightly higher than the rate of 6.1 (95% CI 5.9–6.4) found
in the INICC ICUs overall,12 and signiﬁcantly higher than the NHSN
rate of 3.1 (95% CI 3.0–3.3).
Hand hygiene compliance was similar in this study to that
found in the overall INICC ICUs: 48.6% (95% CI 42.8–54.3) vs. 54.0%
(95% CI 53.6–54.4).12
The mortality of patients without a DA-HAI was higher in this
study than in the overall INICC ICUs: 33.0% (95% CI 29.7–36.4) vs.
14.4% (95% CI 14.1–14.7),12 which may be due to the greater
severity of illness in these ICU patients. CLA-BSI and VAP mortality
were similar in Cuba to those in the overall INICC ICUs.12
The average LOS for patients without a DA-HAI, for those with a
CLA-BSI, and for those with VAP were similar in this study to those
in the overall INICC ICUs.12
Different facts can be listed to explain these DA-HAI rates.
Infection control guidelines on speciﬁc practices are not adhered to
adequately, despite the presence of a national nosocomial infection
prevention program in Cuba (PNPCIN) since 1983. Similarly, there
is a lack of a regulatory legal framework on which to implement
infection control programs, which is a relatively common fact in
most developing countries, according to suggestions found in the
scientiﬁc literature from resource-limited settings. However, in
some developing countries where such regulations are actually in
force, they are not properly applied either.37,38
Additionally, in Cuba, hand hygiene compliance is low in
healthcare facilities, reﬂecting the general situation in other
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developing countries, administrative and ﬁnancial support is
lacking, there are insufﬁcient supplies, and wards are over-
crowded, which almost inevitably results in limited funds and
resource availability to deal with infection control.39 Likewise, it is
almost certain that the low nurse-to-patient stafﬁng ratios also
result in high healthcare-associated infection rates. In addition,
there is an inadequate number of trained staff, which has been
highly associated, togetherwith low nurse-to-patient ratios and an
inexperienced nurse service, with a greatly increased risk of DA-
HAI.40 Finally, in these settings, the use of antiquated technology
may be another underlying factor of the high infection rates.To
help reduce DA-HAI risk in hospitalized patients, the ﬁrst measure
is the implementation of DA-HAI surveillance.2 The second
effective and basic measure is to adopt infection control and
preventive practices for DA-HAIs in hospitals.41–44 It is noteworthy
that disseminating knowledge and accurate information on the
serious public health problem posed by device-associated infec-
tions in these hospital ICUs, can be highly motivating for
developing successful high-quality infection control strategies.
There is evidence suggesting positive modiﬁcations in hospital
practices: hand hygiene compliance has substantially increased,
performance feedback programs for hand hygiene have been
instituted, and central line and urinary catheter care have shown a
signiﬁcantly reduced incidence of CLA-BSI, CAUTIs, and VAP in
several of the hospital members of the INICC.14,45–50
This having been said, this study presents some limitations.
First, the data may not be adequate to reﬂect a whole single
country. During 3 years and 7 months, we prospectively
collected data as an integral part of the implementation of a
comprehensive surveillance system in two Cuban hospital ICUs.
There is a likelihood that variations in the efﬁcacy of
surveillance and the different availability of institutional
resources could have affected the determined rates; this poses
the major limitation. Second, variations in DA-HAI rates among
the INICC member hospitals, and between countries, result in
signiﬁcantly different severity of illness or, in most cases, in
differences in efﬁcacy of surveillance. Third, member hospital
laboratories need to be relied upon in their identiﬁcation of
infecting pathogens and when delineating bacterial resistance
patterns. This is a limitation in that different laboratories may
have widely varying levels of expertise and resource availability;
however, this can also be observed in any other multicenter
clinical surveillance data. Finally, other severity illness scores,
such as the acute physiology and chronic health evaluation
(APACHE) score, were not applied because of the lack of
resources to calculate more labor-intensive scores. Similar to
other cohort studies, the hospitals initiated clinical surveillance
at different time periods, and also their surveillance was
suspended at different time points. This resulted in a lack of
simultaneously collected data from the two hospitals enrolled in
this study.
In conclusion, the fact that DA-HAIs pose a serious and largely
under-recognized threat to patient safety in the developing
countries is of crucial importance. Consequently, the improvement
shown in INICC member hospitals elsewhere can provide
healthcare professionals with simple, inexpensive, but effective,
preventive strategies,14,45–51 leading to increasing acceptance of
infection control programs in all INICC member hospitals, and to
substantial DA-HAI reductions, in particular, of those DA-HAIs that
are acquired in the ICU. For that reason, as in the case of these
Cuban hospitals, any hospital may participate in the INICC
network, which was created as a result of the paramount need
of developing countries to signiﬁcantly prevent, control, and
reduce DA-HAIs and their adverse consequences. In INICC, not only
are investigators freely provided with training andmethodologicaltools to conduct outcome and process surveillance, but through the
publication of these conﬁdentially collected data, relevant
scientiﬁc evidence-based literature is fostered as well.
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